retatrutide triple agonist glp-1 gip glucagon From Obesity to Metabolic Health: Why Is a Game-Changer Retatrutide: Eli Lilly's GLP-1 Triple

Semaglutide clears the body relatively quickly (half-life of 7 days), but this 2-3 month window allows full elimination, metabolic stabilization, and confirms you have established a new baseline before fetal development begins

Seizures cause neuroinflammation, which in turn aggravates epilepsy (12,13)

snack craving that used to be automatic simply does not show up

And so, GLP-1 therapies improve weight, blood sugar and lipid profiles, and some have demonstrated cardiovascular event reduction in high-risk populations, which makes them particularly relevant for patients with RA who also have diabetes or obesity-related cardiovascular risk

Nikan, M

With the thought that GLP-1s would help resolve health disparities, differences in ability to pay may deepen existing health disparities and prevent marginalized communities from benefiting from these potentially life-changing drugs